# Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers

> **NCT01550458** · PHASE1 · COMPLETED · sponsor: **Cavion, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** mibefradil
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01550458
- **Lead sponsor:** Cavion, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-06-24
- **Final completion:** 2012-06-24
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-04-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01550458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01550458, "Safety Study of Mibefradil When Given Four Times a Day in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01550458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*